| mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
-0.0084 |
0.9 |
| mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |